Opinion ID: 4511614
Heading Depth: 3
Heading Rank: 4

Heading: Lavin's New Job at PillPack

Text: In November of 2018, Lavin began discussions with PillPack about possible employment. PillPack is an online retail pharmacy founded in 2013 and wholly owned by Amazon.com, Inc. PillPack aspires to create a new model of providing prescription drugs to patients. Previously, Lavin led CVS Caremark's development of a strategy for determining whether and under what terms to contract with PillPack, which is now enrolled in CVS Caremark's pharmacy network. Neither PillPack nor Amazon.com operates a traditional PBM business. Lavin accepted employment at PillPack on March 29, 2019 and gave CVS his two-week notice on April 8, 2019. In his new position, he will be responsible for negotiating with PBMs and payers.2 Moreover, PillPack's chief executive officer (CEO) stated that he expects Lavin to contribute significantly to 2 During some stages of the litigation, Lavin asserted that his new job will require him to negotiate only with PBMs. The district court found this assertion too modest and determined that Lavin's responsibilities also will include negotiating with payers. See CVS Pharmacy, Inc. v. Lavin, 384 F. Supp. 3d 227, 230, 234 (D.R.I. 2019). Lavin does not challenge this factual finding on appeal. - 7 - [PillPack's] procurement efforts . . . and help [PillPack] develop a long term disruptive strategy. CVS Pharmacy, Inc. v. Lavin, 384 F. Supp. 3d 227, 230 (D.R.I. 2019) (alteration in original). Lavin and PillPack have agreed that he will be recused, at least for some period of time, from any discussions or work involving CVS Caremark or its clients. Those projects will be the responsibility of PillPack's CEO, to whom Lavin will report.